Polycystic ovary syndrome (PCOS) is a common endocrine disorder of reproductive aged women involving overproduction of ovarian androgens, and in some cases from the adrenal cortex. Family studies have established that PCOS is a complex heritable disorder with genetic and epigenetic components. Several small, non-coding RNAs (microRNAs) have been shown to be differentially expressed in ovarian cells, follicular fluid, and in the circulation of women with PCOS. However, there are no reports of global microRNA expression and target gene analyses in ovarian theca cells isolated from normal cycling and PCOS women, which are key to elucidating the basis for the hyperandrogenemia characteristic of PCOS. Using small RNA deep-sequencing, we identified 18 differentially expressed microRNAs in PCOS theca cells, of these, miR-130b-3p was predicted to target one of the PCOS GWAS candidates, DENND1A. We previously reported that DENND1A.V2, a truncated isoform of DENND1A, is upregulated in PCOS theca cells and mediates augmented androgen biosynthesis in PCOS theca cells. Comparison of miR-130b-3p in normal and PCOS theca cells demonstrated decreased miR-130b-3p expression in PCOS theca cells, which was correlated with increased DENND1A.V2, CYP17A1 mRNA and androgen biosynthesis. miR-130b-3p mimic studies established that decreased miR130b-3p is correlated with increased DENND1A.V2 and CYP17A1 expression. Thus, in addition to genetic factors, post-translational regulatory mechanisms via miR-130b-3p underly androgen excess in PCOS. IPA Pathway and Network Analyses suggests a network by which of miR-130b-3p, DENND1A, the LHCGR, RAB5B and the signaling pathways they potentially target may mediate increased hyperandrogenism is PCOS.